Floatz logo

Therapeutic Asset Ratings

470 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Fludarabine
KRAS G12D
Sun Yat-sen UniversityEarly P1C (38)
Fludarabine
KRAS G12V
Sun Yat-sen UniversityEarly P1C (38)
Tcr-T Cells
KRAS G12D
Sun Yat-sen UniversityEarly P1C (38)
Tcr-T Cells
KRAS G12V
Sun Yat-sen UniversityEarly P1C (38)
wtx212a
Cancer
Sun Yat-sen UniversityP1C (37)
ix001 tcr-t
Pancreatic Neoplasm
Sun Yat-sen UniversityP1C (36)
Valproic Acid
Iatrogenic
Sun Yat-sen UniversityC (35)
Atezolizumab
Anti-PD1/PDL1 Antibody
Sun Yat-sen UniversityD (30)
Azacitidine
Adverse Event
Sun Yat-sen UniversityN/AD (30)
Azacitidine
Complete Remission Rate， CRR
Sun Yat-sen UniversityN/AD (30)
Azacitidine
Duration of Response
Sun Yat-sen UniversityN/AD (30)
Azacitidine
Overall Survival
Sun Yat-sen UniversityN/AD (30)
Azacitidine
Progression Free Survival
Sun Yat-sen UniversityN/AD (30)
Carboplatin
Cryoablation
Sun Yat-sen UniversityN/AD (30)
Carboplatin
Pulmonary Metastases
Sun Yat-sen UniversityN/AD (30)
Docetaxel
Immunoscore
Sun Yat-sen UniversityN/AD (30)
Docetaxel
Minimal Residual Disease
Sun Yat-sen UniversityN/AD (30)
Eloxatin
Adverse Event
Sun Yat-sen UniversityN/AD (30)
Eloxatin
Complete Remission Rate， CRR
Sun Yat-sen UniversityN/AD (30)
Eloxatin
Duration of Response
Sun Yat-sen UniversityN/AD (30)
Epirubicin
Immunoscore
Sun Yat-sen UniversityN/AD (30)
Ethiodized Oil
Ablation
Sun Yat-sen UniversityN/AD (30)
Ethiodized Oil
Anti-PD1 Antibody
Sun Yat-sen UniversityN/AD (30)
Ethiodized Oil
Local Therapy
Sun Yat-sen UniversityN/AD (30)
Ethiodized Oil
Surgery
Sun Yat-sen UniversityD (30)
Showing 401 to 425 of 470 assets
PreviousPage 17 of 19Next